From: Evaluating mortality in intensive care units: contribution of competing risks analyses
Variable | Logistic model | Fine and Gray model | ||||
---|---|---|---|---|---|---|
Mortality | Mortality | Discharged alive | ||||
Odds ratio (95% CI) | P value | SHR (95% CI) | P value | SHR (95% CI) | P value | |
Autologous stem cell transplantation | 3.51 (1.37–9.02) | 0.009 | 1.77 (1.00–3.14) | 0.049 | 0.46 (0.23–0.95) | 0.035 |
Clinically documented lung disease | 2.01 (0.79–5.14) | 0.143 | 2.09 (1.05–4.15) | 0.036 | 0.71 (0.47–1.08) | 0.110 |
Absence of congestive heart failure | 0.12 (0.03–0.57) | 0.008 | 0.22 (0.07–0.64) | 0.006 | 2.20 (1.42–3.42) | <0.001 |
Neurological impairment | 2.63 (1.19–5.81) | 0.017 | 1.84 (1.16–2.91) | 0.009 | 0.44 (0.27–0.71) | <0.001 |
Neutropenia | 1.15 (0.53–2.51) | 0.721 | 1.22 (0.73–2.91) | 0.450 | 0.81 (0.50–1.31) | 0.390 |
Logistic organ dysfunction | 1.11 (0.97–1.27) | 0.133 | 1.10 (1.00–1.20) | 0.040 | 0.92 (0.85–1.01) | 0.065 |
Unknown diagnosis | 1.82 (0.85–3.89) | 0.122 | 1.20 (0.72–2.00) | 0.480 | 0.71 (0.40–1.27) | 0.250 |
Acute respiratory distress syndrome | 3.26 (1.42–7.49) | 0.005 | 1.85 (1.21–2.85) | 0.005 | 0.33 (0.19–0.58) | <0.001 |